Focus on Research With James Eliassen, PhD
After studying in the West (Stanford University and the University of California, Davis) and East (Dartmouth College and Brown University), James Eliassen, PhD, settled in the Midwest as a research assistant professor at UC in the department of psychiatry and behavioral neuroscience. He is based at the College of Medicines Center for Imaging Research, where he is associate director. He also holds a secondary appointment as an assistant professor of psychology and is associate director of the Neuroscience Graduate Program.
Why did you come to UC and what brought you here?
"I came to UC in 2003 to pursue research about how the human brain learns simple associations. This research has implications for addiction, which some theories describe as an "associative learning disorder. Aside from the research opportunities and collegial atmosphere, one of the main draws for me was the then new Center for Imaging Research, which houses a state-of-the-art 4 Tesla MRI system. This research-dedicated MRI "brain camera can be used to take pictures of the active human brain while people play simple video or other 'games.'"
Share a bit about your current research focus.
"I am interested in how brain activity changes with learning and how addiction alters the normal behavior of the brain. I have been researching that question using functional MRI, event-related potential EEG and behavior. We study recreational users of MDMA ("ecstasy) and marijuana as well as healthy people. We find that past drug use alters brain activity during associative learning, which supports theories of addiction as an associative learning disorder. We also find that during learning, peoples brains respond differently to positive and negative performance feedback. Peoples brain respond more efficiently to positive feedback, and later performance is faster. With negative feedback there is a larger response and later performance is slower."
What implications might your research have on treatment?
"We are investigating two current implications of this research. First, we want to know if the differences that we see in brain activity for positive and negative feedback arise because we are activating two different learning circuits, one for reward-based learning and another for punishment-avoidance learning. In insects and mollusks, separate dopamine and norepinephrine circuits control reward and punishment-avoidance learning. If this is also true in humans, it could explain why addictions are so difficult to treat. Current treatments attempt to reduce the rewarding or intoxicating aspects of drug abuse. But if people continue addictions because they are avoiding the unpleasant side effects of withdrawal symptoms, a totally different set of brain regions may be involved that are not targeted by current treatments.
"The second, more recent implication of this work is whether learning through positive or negative feedback has implications for education. We are working to understand if brain imaging can be used to better understand different educational approaches. For instance, if brain activity and behavior are more efficient after positive feedback, does it help to use more positive feedback in instructional settings? Alternatively, if negative feedback is less efficient, could it provide longer-lasting learning because it engages more brain activity initially?"
Tell us a bit about yourself. Any hobbies?
"I do some amateur astronomy from my back yard. I visit the Cincinnati Observatory Center whenever possible, which is a UC-supported facility, by the way. I play music with friends occasionally, string bass and drums. I also spend time coaching my kids soccer and basketball teams."
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.